STAMPANONI BASSI, MARIO ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 277
NA - Nord America 212
AS - Asia 211
Totale 700
Nazione #
US - Stati Uniti d'America 200
DE - Germania 151
SG - Singapore 108
HK - Hong Kong 102
IT - Italia 76
EE - Estonia 13
CA - Canada 11
FI - Finlandia 10
GB - Regno Unito 9
RU - Federazione Russa 8
BE - Belgio 5
NL - Olanda 3
BD - Bangladesh 1
CH - Svizzera 1
LT - Lituania 1
MX - Messico 1
Totale 700
Città #
Hong Kong 102
Falkenstein 85
Frankfurt am Main 59
West Jordan 50
Rome 44
Chicago 43
Boardman 30
Singapore 27
Helsinki 10
Moscow 8
Toronto 8
Naples 6
Brussels 5
Buffalo 5
Bologna 4
Charlotte 4
London 4
Sant'Elpidio a Mare 4
Arosio 3
Ashburn 3
Ettlingen 3
Galbiate 3
Ottawa 3
Diano d'Alba 2
Zona Industriale 2
Amsterdam 1
Grellingen 1
Los Angeles 1
Mexico City 1
Totale 521
Nome #
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 27
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 25
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 24
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 24
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 23
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 23
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 21
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 21
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 21
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 21
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients. 21
Obesity worsens central inflammation and disability in multiple sclerosis 21
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 21
Case Report: Overlap Between Long COVID and Functional Neurological Disorders 21
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 20
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 20
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 20
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 20
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 20
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 19
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 19
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. 19
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 18
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 18
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 16
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 16
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 16
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 15
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 15
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 15
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 15
Subclinical dysphagia in task-specific mouth tremor triggered by drinking 14
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 14
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 14
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 14
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 14
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 14
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 14
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 14
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 13
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 12
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 12
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 11
Totale 775
Categoria #
all - tutte 6.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024164 0 0 0 0 0 0 37 0 0 101 15 11
2024/2025611 28 43 7 45 69 42 164 156 41 16 0 0
Totale 775